[Asia Economy Reporter Lee Jung-yoon] Celltrion Healthcare announced on the 18th that it has decided to acquire 630,000 shares of its own stock on the market. The purpose is to stabilize the stock price and enhance shareholder value.



The expected acquisition amount is 39.753 billion KRW, and the expected acquisition period is from the 19th of this month to May 18th.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing